VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Receptors, Formyl Peptide
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial. Am J Kidney Dis. 2023 Feb; 81(2):145-155.e1.
View in:
PubMed
subject areas
Adolescent
Adult
Child
Child, Preschool
Female
Humans
Hyperoxaluria
Hyperoxaluria, Primary
Infant
Infant, Newborn
Kidney Diseases
Male
Middle Aged
Oxalates
Young Adult
authors with profiles
MINI MICHAEL